# China NMPA Drug Inspection - Lepu Pharmaceutical Technology Co., Ltd. - Atorvastatin calcium tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/lepu-pharmaceutical-technology-co-ltd/b05cc04b-8507-45b7-9b99-0eb9a05e2fb9/
Source feed: China

> China NMPA drug inspection for Lepu Pharmaceutical Technology Co., Ltd. published June 17, 2021. Drug: Atorvastatin calcium tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Lepu Pharmaceutical Technology Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Atorvastatin calcium tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/lepu-pharmaceutical-technology-co-ltd/35bacb95-6593-48c1-947f-914646f5bbee/